Gapping up
In reaction to earnings/guidance:
- PDCO +10.6%, GIS +3.1%
Other news:
- XAIR +17.5% (FDA approves LungFit PH to treat neonates with hypoxic respiratory failure)
- ALXO +13.2% (FDA grants orphan drug designation to evorpacept for the treatment of patients with acute myeloid leukemia)
- INO +10.4% (EU announces start of delivery of vaccines in response to the monkeypox outbreak)
- AGEN +7.6% (shows unprecedented activity for botensilimab/balstilimab combination in microsatellite stable colorectal cancer at ESMO World GI Congress)
- LRN +6.9% (to join S&P SmallCap 600)
- FREY +6.5% (Sanctions Construction of its Inaugural Gigafactory)
- KULR +6.5% (receives follow-on phase change material heat sink order from Lockheed Martin (LMT))
- FTDR +6.3% (to join S&P SmallCap 600)
- SNCY +5.9% (to join S&P SmallCap 600)
- ORA +5.4% (to join S&P MidCap 400)
- AGI +3.9% (plans to expand Island Gold mine)
- PINS +3.3% (CEO Ben Silbermann is stepping down; Google exec Bill Ready named new CEO)
- BALY +3.2% (BALY announces sale-leaseback transaction with GLPI for two casinos for $1 bln)
- ACHR +2.4% (says it is confident it will achieve its goal of flying full transition flights with Maker by year end)
- GATO +1.7% (names new CFO)
- IMO +1.4% (announces sale of interests in Montney and Duvernay assets)
- CNNE +1% (completes repurchase of shares held by FNF)
- EVH +1% (acquires IPG for $375 mln plus additional contingent consideration of up to $87 mln; reaffirms Q2 and FY22 outlook)
Analyst comments:
- MCD +0.7% (upgraded to Overweight from Neutral at Atlantic Equities)